These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25464884)
1. Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents. Jiao L; Qiu Q; Liu B; Zhao T; Huang W; Qian H Bioorg Med Chem; 2014 Dec; 22(24):6857-66. PubMed ID: 25464884 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel P-glycoprotein-mediated multidrug resistance inhibitors bearing triazole core via click chemistry. Liu B; Qiu Q; Zhao T; Jiao L; Hou J; Li Y; Qian H; Huang W Chem Biol Drug Des; 2014 Aug; 84(2):182-91. PubMed ID: 24750961 [TBL] [Abstract][Full Text] [Related]
3. 6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance. Liu B; Qiu Q; Zhao T; Jiao L; Li Y; Huang W; Qian H ChemMedChem; 2015 Feb; 10(2):336-44. PubMed ID: 25470220 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors. Wu Y; Pan M; Dai Y; Liu B; Cui J; Shi W; Qiu Q; Huang W; Qian H Bioorg Med Chem; 2016 May; 24(10):2287-97. PubMed ID: 27073052 [TBL] [Abstract][Full Text] [Related]
5. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents. Zou ZH; Lan XB; Qian H; Huang WL; Li YM Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940 [TBL] [Abstract][Full Text] [Related]
7. Discovery to solve multidrug resistance: Design, synthesis, and biological evaluation of novel agents. Qiu Q; Shi W; Zhao S; Zhu Y; Ding Z; Zhou S; Kairuki M; Huang W; Qian H Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900127. PubMed ID: 31441108 [TBL] [Abstract][Full Text] [Related]
8. Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance. Qiu Q; Zhu J; Chen Q; Jiang Z; Xu J; Jiang X; Huang W; Liu Z; Ye J; Xu X Bioorg Chem; 2019 Sep; 90():103083. PubMed ID: 31255991 [TBL] [Abstract][Full Text] [Related]
9. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells. Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of a novel series of inhibitors reversing P-glycoprotein-mediated multidrug resistance. Ghaleb H; Li H; Kairuki M; Qiu Q; Bi X; Liu C; Liao C; Li J; Hezam K; Huang W; Qian H Chem Biol Drug Des; 2018 Sep; 92(3):1708-1716. PubMed ID: 29786944 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells. Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors. Gu X; Ren Z; Tang X; Peng H; Zhao Q; Lai Y; Peng S; Zhang Y Eur J Med Chem; 2012 May; 51():137-44. PubMed ID: 22405646 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents. Tang X; Gu X; Ren Z; Ma Y; Lai Y; Peng H; Peng S; Zhang Y Bioorg Med Chem Lett; 2012 Apr; 22(8):2675-80. PubMed ID: 22450134 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors. Gu X; Ren Z; Tang X; Peng H; Ma Y; Lai Y; Peng S; Zhang Y Bioorg Med Chem; 2012 Apr; 20(8):2540-8. PubMed ID: 22429509 [TBL] [Abstract][Full Text] [Related]
16. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells. Ji BS; He L J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance. Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850 [TBL] [Abstract][Full Text] [Related]